Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Qarziba 4.5 mg/mL concentrate for solution for infusion {equilateral_black_triangle}

Active Ingredient:
dinutuximab beta
Company:  
Recordati UK Ltd See contact details
ATC code: 
L01FX06
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 28 Jun 2024

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Recordati UK Ltd
Company image
Address
Breakspear Park, Breakspear Way, Hemel Hempstead, HP2 4TZ
WWW
https://www.eusapharma.com
Telephone
+44 (0)330 500 1140
Customer Care direct line
+44 (0)330 500 1144
Stock Availability
[email protected]
Medical Information Direct Line
+44 (0)330 500 1155
Medical Information e-mail
[email protected]
Fax
+44 (0)330 500 1154